Modern-day blood analyzers are designed to use a small volume of a patient's blood for measurement. To achieve this, the analyzers employ fluid lines with small bores to transport the blood from a sampling device to sensors and ultimately to a waste container. Because the fluid lines are small, they are susceptible to blockage due to blood clots, protein build-up, and salt crystal growth. Blockage of the fluid lines leads to a loss of functionality of the analyzer.
Liquid wash solution containing anti-microbial agent and surfactants can be cycled through the fluid lines. However, this does not fully prevent biofilm and protein growth over repeated samples. Washing cannot always remove blood clots or other particulates.
Another way of trying to prevent blockages is to replace all the wetted components routinely or when blockages do occur. This generally requires a service technician to visit the site of the analyzer, which takes time and places the analyzer out of use a problem.
Accordingly, a need exists for an improved fluidic tubing assembly in which the functional parts of the assembly are formed as a modular unit and are quickly and easily replaceable by the user if blockage occurs. It is to such a fluidic tubing assembly that the inventive concepts disclosed herein are directed.
The inventive concepts disclosed and claimed herein generally relate to a fluidic tubing assembly for a blood analyzer having a housing supporting a fluid sample assembly, a sensor assembly, and a fluid waste assembly. The fluidic tubing assembly includes a base positionable in the housing of the blood analyzer; a plurality of connectors extending from the base so each of the connectors is removably connectable to at least one of the fluid sample assembly, the sensor assembly, and the fluid waste assembly; and a plurality of tubes where each of the tubes extends from one of the connectors to another one of the connectors to establish fluid communication from one of the connectors to the other connector, wherein fluid communication is established between the fluid sample assembly, the sensor assembly, and the fluid waste assembly through the fluidic tubing assembly when the fluidic tubing assembly is positioned in the housing.
In another aspect, the fluidic tubing assembly includes a base, a first tube, a second tube, a first connector, a second connector, a third connector, and a fourth connector. The base is connectable to the blood analyzer and has a front side, a rear side opposite the front side, a first side, a second side opposite the first side, a top side, and a bottom side opposite the top side. The first tube has a first end and a second end. The second tube has a first end and a second end. The first connector is supported by the first side of the base and defines a first fluid inlet. The first end of the first tube is connected to the first connector. The second connector is supported by the top side of the base and defines a first fluid outlet. The second end of the first tube is connected to the second connector. The third connector is supported by the top side of the base and defines a second fluid inlet. The first end of the second tube is connected to the third connector. The fourth connector is supported by the bottom side of the base and defines a second fluid outlet. The second end of the second tube is connected to the fourth connector.
To assist those of ordinary skill in the relevant art in making and using the inventive concepts disclosed herein, reference is made to the appended drawings and schematics, which are not intended to be drawn to scale, and in which like reference numerals are intended to refer to the same or similar elements for consistency. For purposes of clarity, not every component may be labeled in every drawing. Certain features and certain views of the figures may be shown exaggerated and not to scale or in schematic in the interest of clarity and conciseness. In the drawings:
Before explaining at least one embodiment of the inventive concept(s) in detail by way of exemplary drawings, experimentation, results, and laboratory procedures, it is to be understood that the inventive concept(s) is not limited in its application to the details of construction and the arrangement of the components set forth in the following description or illustrated in the drawings, experimentation and/or results. The inventive concept(s) is capable of other embodiments or of being practiced or carried out in various ways. The language used herein is intended to be given the broadest possible scope and meaning, and the embodiments are meant to be exemplary-not exhaustive. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.
Unless otherwise defined, scientific and technical terms used in connection with the presently disclosed and claimed inventive concept(s) shall have the meanings commonly understood by those of ordinary skill in the art. Further, unless otherwise required by context, singular terms shall include pluralities and plural terms shall include the singular. The foregoing techniques and procedures are generally performed according to conventional methods well known in the art and as described in various general and more specific references cited and discussed throughout the present specification. The nomenclatures utilized in connection with, and the laboratory procedures and techniques of, analytical chemistry, synthetic organic chemistry, and medicinal and pharmaceutical chemistry described herein are those well-known and commonly used in the art. Standard techniques are used for chemical syntheses and chemical analyses.
All the articles, compositions and/or methods disclosed and claimed herein can be made and executed without undue experimentation, given the present disclosure. While the articles, compositions and methods of the inventive concept(s) have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations may be applied to the articles, compositions and/or methods and in the steps or in the sequence of steps of the methods described herein without departing from the concept, spirit and scope of the inventive concept(s). All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the inventive concept(s) as defined by the appended claims.
As utilized under the present disclosure, the following terms, unless otherwise indicated, shall be understood to have the following meanings:
The use of the word “a” or “an” when used in conjunction with the term “comprising” in the claims and/or the specification may mean “one,” but it is also consistent with the meaning of “one or more,” “at least one,” and “one or more than one.”
The use of the term “or” in the claims is used to mean “and/or” unless explicitly indicated to refer to alternatives only or the alternatives are mutually exclusive, although the disclosure supports a definition that refers to only alternatives and “and/or.”
Throughout this application, the term “about” is used to indicate that a value includes the inherent variation of error for the device, the method being employed to determine the value, or the variation that exists among the study subjects.
The use of the term “at least one” will be understood to include one as well as any quantity more than one, including but not limited to, 2, 3, 4, 5, 10, 15, 20, 30, 40, 50, 100, etc. The term “at least one” may extend up to 100 or 1000 or more, depending on the term to which it is attached; in addition, the quantities of 100/1000 are not to be considered limiting, as higher limits may also produce satisfactory results. In addition, the use of the term “at least one of X, Y, and Z” will be understood to include X alone, Y alone, and Z alone, as well as any combination of X, Y, and Z.
As used in this specification and claim(s), the words “comprising” (and any form of comprising, such as “comprise” and “comprises”), “having” (and any form of having, such as “have” and “has”), “including” (and any form of including, such as “includes” and “include”) or “containing” (and any form of containing, such as “contains” and “contain”) are inclusive or open-ended and do not exclude additional, unrecited elements or method steps.
The term “or combinations thereof” as used herein refers to all permutations and combinations of the listed items preceding the term. For example, “A, B, C, or combinations thereof” is intended to include at least one of: A, B, C, AB, AC, BC, or ABC, and if order is important in a particular context, also BA, CA, CB, CBA, BCA, ACB, BAC, or CAB. Continuing with this example, expressly included are combinations that contain repeats of one or more item or term, such as BB, AAA, MB, BBC, AAABCCCC, CBBAAA, CABABB, and so forth. The skilled artisan will understand that typically there is no limit on the number of items or terms in any combination, unless otherwise apparent from the context.
As used herein, the term “sample” and variations thereof is intended to include biological tissues, biological fluids, chemical fluids, chemical substances, suspensions, solutions, slurries, mixtures, agglomerations, tinctures, slides, powders, or other preparations of biological tissues or fluids, synthetic analogs to biological tissues or fluids, bacterial cells (prokaryotic or eukaryotic), viruses, single-celled organisms, lysed biological cells, fixed biological cells, fixed biological tissues, cell cultures, tissue cultures, genetically engineered cells and tissues, genetically engineered organisms, and combinations thereof, for example.
In the following detailed description of embodiments of the inventive concept, numerous specific details are set forth in order to provide a more thorough understanding of the inventive concept. However, it will be apparent to one of ordinary skill in the art that the inventive concept within the disclosure may be practiced without these specific details. In other instances, well-known features have not been described in detail to avoid unnecessarily complicating the instant disclosure.
Finally, as used herein any reference to “one embodiment” or “an embodiment” means that a particular element, feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. The appearances of the phrase “in one embodiment” in various places in the specification are not necessarily all referring to the same embodiment.
Described herein, and shown in the accompanying figures, are several non-limiting embodiments of apparatus of the presently claimed and disclosed inventive concepts which may be used in association with collection syringes and fluid sample analyzers for removing bubbles of air or other gases from a fluid sample for analysis by a fluid sample analyzer. The fluid sample is generally from a biological source. A “fluid” refers to any substance that has no fixed shape and yields easily to external pressure.
Referring now to the drawings, and more particularly to
The blood analyzer 10 includes an enclosure 12 for housing and supporting multiple sample analyzing components and/or modules. These components may include a sample receiving assembly 14, a fluidic tubing assembly 16, a sensor assembly 18, and a reagent assembly 20. The enclosure 12 may also support a display screen 16 for illustrating the progress of a test.
The fluid sample to be introduced to the blood analyzer 10 may comprise any biological material taken from a subject, for example, such as a bodily fluid, infection, or abscess collected from the subject by suitable methods and devices known in the art. Bodily fluids include but are not limited to urine, whole blood, blood serum, blood plasma, saliva, cerebrospinal fluid, pleural fluid, dialysate fluid, nasopharyngeal swabs, vaginal swabs, tears, tissues, and the like. The sample may further include any suitable buffers, diluents, or the like as needed or desired for the particular sample. In particular embodiments, the sample comprises a blood sample, which may be: a whole blood sample comprising plasma and whole blood cells; a plasma sample; or a serum sample. In a particular embodiment, the sample comprises a whole blood sample. The whole blood sample may comprise red blood cells, platelets and the like. In other embodiments, the blood sample comprises a plasma sample. To obtain the plasma sample, the sample may have been treated to remove a plurality of the whole blood cells using known methods and components such as centrifugation or commercially available porous membranes.
The sample receiving assembly 14 is adapted for introducing a liquid sample from a transport container (not shown) to the sensor assembly 18 for analysis. An example of a sample receiving assembly 14 is disclosed in U.S. Pat. No. 10,928,409, which is hereby expressly incorporated herein by reference. In one example, the sample receiving assembly 14 includes a sample probe 24 that may be rotatable to selected positions so the sample probe 24 can receive a fluid sample from different types of sample transport containers. Examples of sample transport containers are syringes, vacutainers, and capillary tubes (not shown). The sample probe 24 may also be oriented in a stand-by mode (e.g., vertically) to seal against a fluid outlet 26 of the reagent assembly 20 whereby the sample receiving assembly 12 is used to transport fluid from the reagent assembly 20 to the sensor assembly 18.
The reagent assembly 20 holds a plurality of reagent fluids used in the test. The reagents may be provided in reservoirs, such as sealed bags or bottles (not shown). The reagent assembly 20 may comprise one or several reservoirs pre-filled with process liquids (as known to a person skilled in the art: QC1, QC2, QC3, CRL3 (S1940), CRL2 (S1930), RINSE/CAL1 (S1920)) having a known composition. The skilled person will appreciate that other chemicals may be provided dependent on the exact test required.
The reagent assembly 20 may include a rubber teat (not shown) defining the fluid outlet 26, for example, such that when brought into sealing engagement with sample receiving assembly 14, the reagent assembly 20 is in fluid communication with the sensor assembly 18 enabling reagent fluid to flow from the reagent assembly 20 to the sensor assembly 18. The reagent assembly 20 can be integrated as part of the blood analyzer 10 or may otherwise be configured to be removable/disposable.
The sensor assembly 18 includes sensors (not shown) which are used to contact a fluid sample. Typically, the sensors of the sensor assembly 18 contain sensors comprising rare metal alloys (such as vanadium bronze) and functionalized with membranes holding active ingredients. The sensor assembly 18 may be integrated into the blood analyzer 10 or may otherwise be removable/disposable.
The sensor assembly 18 may be in direct or indirect communication with a computing unit (not shown) which may collect, store, and analyze analytical test results from the sensors according to known methods.
After delivery of a fluid sample to the sensor assembly 18, the blood analyzer 10 may introduce the fluids from the reagent assembly 20 and prepare the blood analyzer 10 for introduction of a subsequent fluid sample.
Following an analysis of a fluid sample, fluid sample and/or expended reagent is transported to a waste fluid collection member (not shown), such as a bag, pouch, or reservoir (not shown). In one embodiment, the waste fluid collection member may be incorporated as part of the reagent assembly 20.
Referring now to
The base 32 supports the others parts of the fluidic tubing assembly 16 so a fluid path is established between the components while allowing the fluidic tubing assembly 16 to be easily replaced. In a non-limiting example, the base 32 has a generally rectangular configuration with a front side 50, a rear side 52 opposite the front side 50, a first side 54, a second side 56 opposite the first side 54, a top side 58, and a bottom side 60 opposite the top side 58. The base 32 may be formed of multiple parts. For example, the base 32 may include two main parts—an interior portion 62 and an exterior portion 64. The interior portion 62 supports the fluidic components of the fluidic tubing assembly 16 and the exterior portion 64 serves as an exterior covering. It should be appreciated that the base 32 may be formed in a variety of ways and with a variety of parts. For example, the base 32 may be formed as a single piece.
Referring to
Best shown in
The first connector 38 is adapted to mate with a fluid outlet 82 of the sample receiving assembly 16 in a way that fluid communication is established between the sample receiving assembly 16 and the first end 74 of the first tube 34 and in a way that the first connector 38 can be quickly disconnected from the fluid outlet 82 of the sample receiving assembly 16.
In one embodiment, the first connector 38 has a nipple 84 (
The second connector 40 is adapted to mate with a fluid inlet (represented by arrow 92 in
In one embodiment, the second connector 40 has a nipple 94 (
The third connector 42 is adapted to mate with a fluid outlet (represented by the arrow 102 in
In one embodiment, the third connector 42 has a nipple 104 (
Because both the second connector 40 and the third connector 42 interface with the sensor assembly 18, the second connector 40 and the third connector 42 may be arranged in a side-by-side relationship to facilitate simultaneous connection with the sensor assembly 18 and simultaneous disconnection from the sensor assembly 18. The top side 58 of the base 32 may include a recess 112. The recess 112 is mateable with a male portion (not shown) of the sensor assembly 18. The nipple 94 of the second connector 40 and the nipple 104 of the third connector 42 may be secured to the base 32 with a retainer 114 (
Referring to
In one embodiment, the fourth connector 44 has a nipple 118 extending away from the base 32 and slidingly mateable with the fluid inlet 116 of the waste conduit 30. The nipple 118 has a flow passage 120 (
The fourth connector 44 extends from the distal end 124 of the arm 121 and defines a second fluid outlet. The second end 80 of the second tube 36 is connected to the fourth connector 44 to establish fluid communication with the flow passage 120 of the nipple 118. The fourth connector 44 may also include a seal member 130 positioned between the second end 80 of the second tube 36 and the nipple 118 to form a fluid tight seal. It should be appreciated the fourth connector 42 may be formed in any shape connectable to and disconnectable from the fluid inlet 116 of the waste conduit 30.
Each of the first connector 38, the second connector 40, the third connector 42, and the fourth connector 44 has been illustrated as being separate components from the base 32. It will be appreciated, however, that any number of the connectors 38-44 may be formed as a part of the base during the manufacturing process, such as by a suitable molding process.
In use, the fluidic tubing assembly 16 is inserted into and secured within the enclosure 12. The first connector 38 is connected to the fluid outlet 82 of the sample receiving assembly 14. In one embodiment, the sample receiving assembly 14 is moved axially into engagement with the first connector 38 either manually or mechanically. The second connector 40 and the third connector 42 are connected to fluid inlet 92 and the fluid outlet 102 of the sensor assembly 18, respectively. In one embodiment, the sensor assembly 18 is moved axially as a unit into engagement with the second connector 40 and the third connector 42 either manually or mechanically. The fourth connector 44 is connected to the fluid inlet 116 of the waste conduit 30. In one embodiment, the reagent assembly 20 is moved axially as a unit into engagement with the fourth connector 44 either manually or mechanically. It should be appreciated that the order of connection may be varied.
After a predetermined number of tests or upon determining the fluidic tubing assembly 16 has a blockage, the fluidic tubing assembly 16 may be removed from the enclosure 12 as a unit by disconnecting the first connector 38 from the fluid outlet 82 of the sample receiving assembly 14. Removal of the modular fluidic tubing assembly 16 effectuates a disconnection of the tubing between the sample receiving assembly 14, the sensor assembly 18, and the waste conduit 30. In one embodiment, the sample receiving assembly 14 may be moved axially away from the first connector 38 and removed from the enclosure 12. The second connector 40 and the third connector 42 are disconnected from the fluid inlet 92 and the fluid outlet 102 of the sensor assembly 18, respectively. In one embodiment, the sensor assembly 18 is disengaged from the second and third connectors 40 and 42 by moving the sensor assembly 18 axially away from the second connector 40 and the third connector 42. The fourth connector 44 is disconnected from the fluid inlet 116 of the waste conduit 30. In one embodiment, the reagent assembly 20 is disengaged from the fourth connector 44 by moving the reagent assembly 20 axially away from the fourth connector 44. The fluidic tubing assembly 16 is then removed from the enclosure 12.
Referring now to
The base 32a supports the others parts of the fluidic tubing assembly 16a including the CO-oximetry optical cell 140, so a fluid path is established between the components while allowing the fluidic tubing assembly 16a to be easily replaced. In a non-limiting example, the base 32a has a generally rectangular configuration with a front side 50a, a rear side 52a opposite the front side 50a, a first side 54a, a second side 56a opposite the first side 54a, a top side 58a, and a bottom side 60a opposite the top side 58a.
In one non-limiting embodiment, the base 32a supports the CO-oximetry optical cell 140. CO-oximetry is a spectroscopic or optical technique that is used to measure the amount of different Hemoglobin (Hb) species present in a blood sample, for example, Oxy-Hb, Deoxy-Hb, Met-Hb, Carboxy-Hb and Total-Hb. The CO-oximetry optical cell 140 may include a printed circuit board 142, a transducer 144, an optical cell 146, a cover 148, a first connector 150, and a second connector 152. The optical cell 146 may be formed of an upper transparent layer 154 and a lower transparent layer 156 cooperating to form a channel 158. The cover 148 has an opening 160 so a light source (not shown) incorporated as part of the blood analyzer 10 may be received by the fluid sample flowing through the channel 158. The first connector 150 and the second connector 152 are fluidically connected to the channel 158 to form an inlet and an outlet of the channel 158. An exemplary CO-oximetry optical cell is disclosed in PCT/US2021/029119, which is hereby incorporated herein by reference.
As shown in
In another embodiment, the CO-oximetry optical cell 140 may be fluidically interposed in the first tube 34a between the first connector 38 and the second connector 40. In this instance, the first tube 34a may be formed of one or more sections.
In use, the fluidic tubing assembly 16a is inserted into and secured within the enclosure 12 the same as described above for the fluidic tubing assembly 16. After a predetermined number of tests or upon determining the fluidic tubing assembly 16a has a blockage, the fluidic tubing assembly 16a may be removed from the enclosure 12 as a unit similar to manner described above for the fluidic tubing assembly 16.
From the above description, it is clear that the inventive concept(s) disclosed herein is well adapted to carry out the objects and to attain the advantages mentioned herein as well as those inherent in the inventive concept disclosed herein. While exemplary embodiments of the inventive concept disclosed herein have been described for purposes of this disclosure, it will be understood that numerous changes may be made which will readily suggest themselves to those skilled in the art and which are accomplished without departing from the scope of the inventive concept disclosed herein and defined by the appended claims.
The following is a list of non-limiting illustrative embodiments of the inventive concepts disclosed herein:
An illustrative fluidic tubing assembly for a blood analyzer having a housing supporting a fluid sample assembly, a sensor assembly, and a fluid waste assembly, the fluidic tubing assembly comprising:
The illustrative fluidic tubing assembly of any one of the preceding illustrative embodiments further comprising a CO-oximetry optical cell having a channel fluidically interposed between at least two of the connectors.
An illustrative fluidic tubing assembly for a blood analyzer, comprising:
The illustrative fluidic tubing assembly of any one of the preceding illustrative embodiments wherein the first connector has a nipple extending away from the base.
The illustrative fluidic tubing assembly of any one of the preceding illustrative embodiments wherein the second connector has a nipple extending away from the base.
The illustrative fluidic tubing assembly of any one of the preceding illustrative embodiments wherein the third connector has a nipple extending away from the base.
The illustrative fluidic tubing assembly of any one of the preceding illustrative embodiments wherein the fourth connector has a nipple extending away from the base.
The illustrative fluidic tubing assembly of any one of the preceding illustrative embodiments wherein each of the first connector, the second connector, the third connector, and the fourth connector has a nipple extending away from the base.
The illustrative fluidic tubing assembly of any one of the preceding illustrative embodiments wherein the top side of the base has a recess, and wherein the second connector and the third connector are positioned within the recess.
The fluidic tubing assembly of any one of the preceding illustrative embodiments wherein each of the second connector and the third connector has a nipple extending away from the base.
The illustrative fluidic tubing assembly of any one of the preceding illustrative embodiments wherein the bottom side of the base has a downwardly extending arm with a proximal end and a distal end, and wherein the fourth connector is supported by the arm adjacent the distal end thereof.
The illustrative fluidic tubing assembly of any one of the preceding illustrative embodiments wherein the fourth connector has a nipple extending away from the arm.
The illustrative fluidic tubing assembly of any one of the preceding illustrative embodiments wherein the arm has a front side and a rear side, and wherein the second tube extends from the top side of the base, downwardly through the arm from the front side to the rear side, and back through the arm from the rear side to the front side.
The illustrative fluidic tubing assembly of any one of the preceding illustrative embodiments wherein first side of the base has a first rail extending from the rear side toward the front side, and wherein the second side of the base has a second rail extending from the rear side toward the front side.
The illustrative fluidic tubing assembly of any one of the preceding illustrative embodiments further comprising a CO-oximetry optical cell having a channel fluidically interposed between at least one of the first connector and the second connector and the third connector and the fourth connector tube.
The illustrative fluidic tubing assembly of any one of the preceding illustrative embodiments further comprising a CO-oximetry optical cell having a channel fluidically interposed between the third connector and the fourth connector.
An illustrative blood analyzer, comprising
The illustrative blood analyzer of any one of the preceding illustrative embodiments wherein the fluidic tubing assembly comprises a CO-oximetry optical cell having a channel in fluid communication with the sensor assembly, the fluid waste assembly, and the sample receiving assembly.
The illustrative blood analyzer of any one of the preceding illustrative embodiments, wherein the first connector has a nipple extending away from the base.
The illustrative blood analyzer of any one of the preceding illustrative embodiments wherein the second connector has a nipple extending away from the base.
The illustrative blood analyzer of any one of the preceding illustrative embodiments wherein the third connector has a nipple extending away from the base.
The illustrative blood analyzer of any one of the preceding illustrative embodiments wherein the fourth connector has a nipple extending away from the base.
The illustrative blood analyzer of any one of the preceding illustrative embodiments wherein each of the first connector, the second connector, the third connector, and the fourth connector has a nipple extending away from the base.
The illustrative blood analyzer of any one of the preceding illustrative embodiments wherein the top side of the base has a recess, and wherein the second connector and the third connector are positioned within the recess.
The illustrative blood analyzer of any one of the preceding illustrative embodiments wherein each of the second connector and the third connector has a nipple extending away from the base.
The illustrative blood analyzer of any one of the preceding illustrative embodiments wherein the bottom side of the base has a downwardly extending arm with a proximal end and a distal end, and wherein the fourth connector is supported by the arm adjacent the distal end thereof.
The illustrative blood analyzer of any one of the preceding illustrative embodiments wherein the fourth connector has a nipple extending away from the arm.
The illustrative blood analyzer of any one of the preceding illustrative embodiments wherein the arm has a front side and a rear side, and wherein the second tube extends from the top side of the base, downwardly through the arm from the front side to the rear side, and back through the arm from the rear side to the front side.
The illustrative blood analyzer of any one of the preceding illustrative embodiments wherein first side of the base has a first rail extending from the rear side toward the front side, and wherein the second side of the base has a second rail extending from the rear side toward the front side.
An illustrative method of providing fluid passage in a blood analyzer, the blood analyzer having a housing, a sample receiving assembly, a sensor assembly, and a fluid waste assembly, the method comprising:
The illustrative method of any one of the preceding illustrative embodiments wherein the fluidic tubing assembly is a first fluidic tubing assembly, and wherein the method further comprises:
This application claims benefit under 35 USC § 119(e) of U.S. Provisional Application No. 63/270,206, filed Oct. 21, 2021. The entire contents of the above-referenced patent application are hereby expressly incorporated herein by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2022/078190 | 10/17/2022 | WO |
Number | Date | Country | |
---|---|---|---|
63270206 | Oct 2021 | US |